UPSTREAMBIO
Live / Allowed — Fourth extension granted (statement of use) (as of 24 Jun 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Jun 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97459993
- Mark type
- Word mark
- Filed
- 15 Jun 2022
- Published for opposition
- 09 May 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and biologic preparation for the treatment of allergic and inflammatory diseases, including asthma
- Class 042 — Scientific and technological services: Scientific research and development services in the nature of pharmaceutical preparations and biologic preparations for the treatment of allergic and inflammatory diseases, including asthma
Owner
- Upstream Bio, Inc., Waltham, MA, US
- Upstream Bio, Inc., Waltham, MA, US
Prosecution history
- 14 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 18 Dec 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2025 — SOU EXTENSION 4 GRANTED
- 24 Jun 2025 — SOU EXTENSION 4 FILED
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2024 — SOU EXTENSION 3 GRANTED
- 04 Dec 2024 — SOU EXTENSION 3 FILED
- 04 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — SOU EXTENSION 2 GRANTED